[CAS NO. 1429321-13-0]  TA-316

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [1429321-13-0]

Catalog
HY-112486
Brand
MCE
CAS
1429321-13-0

DESCRIPTION [1429321-13-0]

Overview

MDL-
Molecular Weight641.56
Molecular FormulaC28H25BrN4O5S2
SMILESO=C(C1=CC=C(C(NCC2=CC=C(C(NCCO)=O)C=C2)=O)S1)N/N=C(C3=CSC(C4=CC=C(Br)C=C4)=C3O)\C

For research use only. We do not sell to patients.

Summary

TA-3166 (Megakaryocytes/platelets inducing agent) is a novel chemically synthesized c-MPL agonist (CMA) and thrombopoietin (TPO) receptor agonist. TA-316 enhances ex vivo platelet generation from human-induced pluripotent stem (iPS) cells [1] [2] .


In Vitro

TA-316 (0.01-1000 nM; 4 days) stimulates UT-7/TPO and Ba/F3-HuMpl cells proliferation, with the EC 50 values of 0.3 and 0.65 nM, respectively [2] .
TA-316 (800 nM; 10 days) promotes biased megakaryopoiesis and upregulated MK lineage markers [2] .
TA-316 (200 nM; 4 days) preferentially enhances VEGFA and FGF2 expression [2] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay [2]

Cell Line: UT-7/TPO and Ba/F3-HuMpl cells
Concentration: 0.01-1000 nM
Incubation Time: 4 days
Result: Stimulated UT-7/TPO and Ba/F3-HuMpl cell proliferation.

Appearance

Solid


Shipping

Room temperature in continental US; may vary elsewhere.


Storage

Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month

Solvent & Solubility

In Vitro:

DMSO : 50 mg/mL ( 77.94 mM ; ultrasonic and warming and heat to 60°C)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 1.5587 mL 7.7935 mL 15.5870 mL
5 mM 0.3117 mL 1.5587 mL 3.1174 mL
10 mM 0.1559 mL 0.7794 mL 1.5587 mL
* Please refer to the solubility information to select the appropriate solvent.